We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Rafael Holdings Inc (RFL) USD0.01 B

Sell:$1.69 Buy:$1.71 Change: $0.01 (0.58%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Sell:$1.69
Buy:$1.71
Change: $0.01 (0.58%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Sell:$1.69
Buy:$1.71
Change: $0.01 (0.58%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.

Contact details

Address:
520 Broad St
NEWARK
07120
United States
Telephone:
+1 (212) 6581450
Website:
https://rafaelholdings.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
RFL
ISIN:
US75062E1064
Market cap:
$42.04 million
Shares in issue:
24.58 million
Sector:
Real Estate Operating Companies
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Howard Jonas
    Executive Chairman of the Board
  • William Conkling
    President, Chief Executive Officer
  • David Polinsky
    Chief Financial Officer
  • John Goldberg
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.